Senior insider sale
CEO and Chairman at CADRENAL THERAPEUTICS, INC. — senior position signals high conviction
$348.6K
60K shares
What this filing means
PHAM QUANG X plans to sell 60K shares of CADRENAL THERAPEUTICS, INC. valued at approximately $348.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001628280-26-033592
DirectorOfficer10% Owner· CEO and Chairman
Since Jan 2023
60K
Shares to sell
$348.6K
Approx. market value
60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Founders Shares
N/A
1/25/2022
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/25/2022 | Founders Shares N/A | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
60K
Market value
$348.6K
5/11/2026
Total
Units
60K
Value
$348.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/11/2026 | 60K | $348.6K | NASDAQ | Planned |
| Total | 60K | $348.6K | ||